Givaudan SA (OTCMKTS:GVDNY – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $82.6950, but opened at $77.23. Givaudan shares last traded at $77.42, with a volume of 1,001 shares.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on GVDNY shares. Berenberg Bank downgraded Givaudan from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. Kepler Capital Markets cut Givaudan from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 13th. Zacks Research raised shares of Givaudan from a “strong sell” rating to a “hold” rating in a report on Monday, May 18th. Barclays lowered shares of Givaudan from a “strong-buy” rating to a “hold” rating in a research report on Friday, March 27th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Givaudan from a “hold” rating to a “buy” rating in a research report on Tuesday, June 9th. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Givaudan presently has an average rating of “Hold”.
Check Out Our Latest Analysis on GVDNY
Givaudan Price Performance
About Givaudan
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Further Reading
- Five stocks we like better than Givaudan
- Alphabet Crushed Earnings, But One Number Spooked the Market
- Otis Took Another Guidance Cut—But the Story Isn’t Over
- Is Buying a Launch Company AST SpaceMobile’s Next Vertical Integration Move?
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
